Guardant Health Reports Second Quarter 2020 Financial Results

NEXT STORY
Ziopharm Oncology Reports Second Quarter 2020 Financial Results and Provides Corporate Update
PREV STORY
Dynavax Announces Second Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Antares Receives FDA Approval of Xyosted™ (Testosterone Enanthate) Injection for Testosterone Replacement Therapy in Adult Males

 A Novel Subcutaneous Auto Injector Product Approved For Once-Weekly At-Home Therapy EWING, N.J., Oct. ...

author_avatar
NASDAQ Market News

Motif Bio Appoints Scientific Opinion Leaders to Advisory Board

NEW YORK, May 10, 2017 (GLOBE NEWSWIRE) -- Motif Bio plc (NASDAQ:MTFB) (AIM:MTFB.LN), a ...

author_avatar
NASDAQ Market News

XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with OnivydeⓇ and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer

AUSTIN, Texas, Sept. 20, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today its ...

author_avatar
NASDAQ Market News